ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias

Three clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated significant positive results from novel triplet therapies in the treatment of relapsed or refractory and newly diagnosed leukemias. The results were presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. More information on all ASH Annual Meeting content from MD Anderson can be found at MDAnderson.org/ASH.

Could Venetoclax Improve Outcomes of CAR T for Patients with Resistant B-Cell Lymphomas? New Insights at ASH

About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing form of lymphoma, will see their disease advance or recur following treatment. Seeking a new treatment strategy that might boost the effectiveness of existing DLBCL therapies, a team from Roswell Park has been working to understand the underlying mechanisms of the targeted chemotherapy venetoclax. Their findings, to be presented during a talk today at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California, provide strong preclinical evidence that adding venetoclax to standard treatment may improve outcomes in patients with treatment-resistant B-cell lymphomas.

ASH: Monoclonal antibody therapy improves survival in cancer-associated hyper-inflammatory disorder

Adult patients with newly diagnosed malignancy-associated hemophagocytic lymphohistiocytosis (mHLH) – a rare, aggressive hyperinflammatory condition – who were treated with the first-in-class monoclonal antibody, ELA026, experienced a 100% response rate and an improved survival rate at two months, according to researchers from The University of Texas MD Anderson Cancer Center.

Lighting Campus for Hope: A Winter Wonderland of Resilience and Community

More than just a holiday gathering, this free, family-friendly event marked the culmination of a year-long appeal that raised $255,000 to provide 1,350 life-saving cancer screenings in our Borderplex community. Every dollar from event sponsorships will directly support cancer screenings and diagnostics, emphasizing the transformative impact of early detection and care.

Experts debate management of patient with gastroesophageal reflux symptoms

In a new Annals “Beyond the Guidelines” feature, two physicians, a primary care practitioner and a gastroenterologist, discuss the management of a patient with gastroesophageal reflux disease (GERD) symptoms. GERD is a common medical condition presenting with heartburn, regurgitation, cough, hoarseness and/or wheezing.

The VR Technologist Will See You Now

If your heart rate increases each time you hear the word “injection,” you’re not alone. Every 1 in 4 adults has a fear of needles—a fear that most attribute to an experience they had when they were children.For kids who visit the hospital frequently, anxiety around even routine procedures might interfere with each visit and even lead to long-term trauma.

STUDENTS ARE LESS LIKELY TO FEEL SAFE AT THEIR SCHOOLS, COMPARED TO STAFF AND PARENTS

Researchers at the University of Southern California (USC) conducted a nationwide study of K-12 parents, K-12 teachers, and recently graduated high school students to test their responses to three hypothetical “threat scenarios.” The goal was to measure their perception of school safety as well as their likelihood to report a threat at school.

Chula Pioneers Responsible Use of Generative AI for Higher Education in Thailand with the Inauguration of ‘ChulaGENIE,’ in Collaboration with Google Cloud

Chulalongkorn University (Chula), Thailand’s pre-eminent higher education institution, and Google Cloud today announced the inauguration of ChulaGENIE, a continuous application delivery project that makes the world’s most advanced generative AI (gen AI) capabilities safely, securely, and freely available to Chula’s entire community. ChulaGENIE will be initially available to Chula staff and faculty members in January 2025, with all students receiving access in March 2025. ChulaGENIE stands for ‘Chula’s Generative AI Environment for Nurturing Intelligence and Education.’

New Study Reveals Key Insights on Sarcoma Rates in Military vs. Civilian Men

Researchers at the Uniformed Services University of the Health Sciences (USU) have uncovered compelling insights into the incidence of soft tissue sarcomas among U.S. active-duty servicemen, revealing significant age-related differences compared to the general male population. The findings shed light on the interplay between occupational exposures, healthcare access, and cancer risk, paving the way for targeted prevention strategies and future research.

Children’s Hospital of Philadelphia Researchers Find Rotavirus Vaccine is Safe for Use in NICU Babies

Researchers found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, strongly suggesting that giving the rotavirus vaccine to eligible infants during their hospitalization provides immune benefits that outweigh any risks. The findings could serve as the basis for a change in clinical practice.

Developing wastewater treatment units that treat right where it’s generated

Dr. Sang Hoon Kim, Extreme Materials Research Center, Dr. Jong Min Kim, Materials Architecturing Research Center, and Dr. Sang Soo Han, Computation Science Research Center, all from the Korea Institute of Science and Technology (KIST), have developed an electrochemical device that can treat sewage and wastewater from pollution sites to the level of discharge. In particular, it can rapidly and completely decompose recalcitrant materials into inorganic substances and discharge them on its own.

Resistance Training Can Reduce Fatigue, Pain in Multiple Myeloma Patients, Roswell Park Team Shows

Researchers from Roswell Park Comprehensive Cancer Center will present compelling findings showcasing significant benefits of resistance training for patients with multiple myeloma, in a talk at the 66th American Society of Hematology (ASH) Annual Meeting. The study, led by Jens Hillengass, MD, PhD, and Janine Joseph, MS, MBA, presents new evidence documenting that targeted exercise regimens can alleviate fatigue, improve sleep and reduce pain, offering new hope for enhancing quality of life in cancer care.

Roswell Park Experts Report Insights on CAR T for Follicular Lymphoma, KEYNOTE-667 Combo in Hodgkin Lymphoma

The results of two important lymphoma studies led by experts at Roswell Park Comprehensive Cancer Center will be presented during oral abstract sessions this morning at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California. Lymphoma is a type of blood cancer that causes white blood cells called lymphocytes to grow out of control and behave abnormally.

Multi-center study shows education level, income impact access to stem cell transplantation for acute myeloid leukemia patients

Patients with acute myeloid leukemia who have lower education levels and lower income are less likely to receive a allogeneic hematopoietic stem cell transplant for acute myeloid, however, if they can access the treatment, are equally likely to benefit from transplant as patients with more education and higher income, according to a new study from Fred Hutch Cancer Center presented at the annual meeting of the American Society of Hematology.

Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias

A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows that gilteritinib (brand name Xospata), a targeted cancer treatment, can strengthen chimeric antigen receptor (CAR) T-cell immunotherapy in two high-risk pediatric leukemias that have poor survival rates — FLT3-mutated acute myeloid leukemia (AML) and KMT2A-rearranged acute lymphoblastic leukemia (ALL). Lisa Niswander, MD, PhD, Assistant Professor of Oncology in the Department of Pediatric Oncology, will deliver the results this afternoon in an oral abstract session at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California.

Roswell Park Study Reveals How Venetoclax Boosts Immune Response to CAR T for Chronic Lymphocytic Leukemia

Research out of Roswell Park Comprehensive Cancer Center has shed light on how the drug venetoclax (brand name Venclexta) works synergistically with CAR T-cell immunotherapy to combat chronic lymphocytic leukemia (CLL), the most common type of leukemia in the U.S. Matthew Cortese, MD, MPH, Assistant Professor of Oncology in Roswell Park’s departments of Medicine and Cancer Genetics & Genomics, is first author of the study, which he will present during an oral abstract session today at the 66th annual meeting of the American Society of Hematology (ASH) in San Diego, California.

Keto diet metabolite may power up CAR T cells to kill cancer

A simple dietary supplement may provide a new approach to boost CAR T cell function, according to a study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center, presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (Abstract 4).

New Research from Children’s Hospital of Philadelphia to Transform Standard of Care Across the Globe for Newly Diagnosed Children with B-cell Acute Lymphoblastic Leukemia

Researchers at Children’s Hospital of Philadelphia (CHOP) and the Children’s Oncology Group (COG) announced the results of a Phase 3 study that demonstrated adding the bi-specific T-cell engager, blinatumomab, to chemotherapy for newly diagnosed National Cancer Institute (NCI) standard risk (SR) B-cell acute lymphoblastic leukemia (B-ALL) pediatric patients significantly improves survival outcomes. The results were published today in the New England Journal of Medicine and will be presented during the plenary session at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition in San Diego on December 8.

Cedars-Sinai Pharmacists Attending Midyear Clinical Meeting 2024

Cedars-Sinai experts in pharmacy services attending the Dec. 8-12 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting 2024 in New Orleans are available for interviews about the latest developments in patient safety and pharmacy practice.

How Caregivers of People With Dementia Can Navigate the Holidays

Although the holiday season brings joy to many, it may mean added stress for those supporting a family member with memory loss. Mary-Catherine Lundquist, the program director of Care2Caregivers, a peer counseling helpline (800-424-2494) for caregivers of individuals with Alzheimer’s disease and related memory disorders operated by Rutgers Behavioral Health Care, discusses how families can make the most of the season.

Navigating the holiday season: MSU experts can comment

It’s the most wonderful time of the year, right? Not necessarily. We all know that the holidays can cause stress and angst as we cook, shop, entertain and spend time with family and friends we may not see often. Michigan State University experts offer suggestions on navigating the holiday — from the economy and food prices to religion and spirituality to health and relationships.

Calculation Sharpens Imaging of Protons’ Insides

Nuclear scientists used a new theoretical approach to calculate a value essential for unraveling the three-dimensional motion of quarks within a proton. The researchers obtained a significantly more accurate picture of these internal building blocks’ transverse motion. The work will aid in calculations of 3D motion of quarks and gluons in future collider experiments.

Dark Energy Camera Spies the Outskirts of the Swirling Southern Pinwheel Galaxy

Twelve million light-years away lies the galactic masterpiece Messier 83, also known as the Southern Pinwheel Galaxy. Its swirling spiral arms display a high rate of star formation and have been host to six observed supernovae. This image was captured with the Department of Energy-fabricated Dark Energy Camera, mounted on the U.S. National Science Foundation Víctor M. Blanco 4-meter Telescope at Cerro Tololo Inter-American Observatory in Chile, a Program of NSF NOIRLab.